Social media behavior is associated with vaccine hesitancy. 2022

Steve Rathje, and James K He, and Jon Roozenbeek, and Jay J Van Bavel, and Sander van der Linden
Department of Psychology & Center for Neural Science, New York University, New York, NY 10003,USA.

Understanding how vaccine hesitancy relates to online behavior is crucial for addressing current and future disease outbreaks. We combined survey data measuring attitudes toward the COVID-19 vaccine with Twitter data in two studies (N 1 = 464 Twitter users, N 2 = 1,600 Twitter users) with preregistered hypotheses to examine how real-world social media behavior is associated with vaccine hesitancy in the United States (US) and the United Kingdom (UK). In Study 1, we found that following the accounts of US Republican politicians or hyper-partisan/low-quality news sites were associated with lower confidence in the COVID-19 vaccine-even when controlling for key demographics such as self-reported political ideology and education. US right-wing influencers (e.g. Candace Owens, Tucker Carlson) had followers with the lowest confidence in the vaccine. Network analysis revealed that participants who were low and high in vaccine confidence separated into two distinct communities (or "echo chambers"), and centrality in the more right-wing community was associated with vaccine hesitancy in the US, but not in the UK. In Study 2, we found that one's likelihood of not getting the vaccine was associated with retweeting and favoriting low-quality news websites on Twitter. Altogether, we show that vaccine hesitancy is associated with following, sharing, and interacting with low-quality information online, as well as centrality within a conservative-leaning online community in the US. These results illustrate the potential challenges of encouraging vaccine uptake in a polarized social media environment.

UI MeSH Term Description Entries

Related Publications

Steve Rathje, and James K He, and Jon Roozenbeek, and Jay J Van Bavel, and Sander van der Linden
January 2024, PNAS nexus,
Steve Rathje, and James K He, and Jon Roozenbeek, and Jay J Van Bavel, and Sander van der Linden
October 2020, BMJ global health,
Steve Rathje, and James K He, and Jon Roozenbeek, and Jay J Van Bavel, and Sander van der Linden
July 2019, BMJ (Clinical research ed.),
Steve Rathje, and James K He, and Jon Roozenbeek, and Jay J Van Bavel, and Sander van der Linden
May 2023, Telematics and informatics,
Steve Rathje, and James K He, and Jon Roozenbeek, and Jay J Van Bavel, and Sander van der Linden
February 2022, Translational behavioral medicine,
Steve Rathje, and James K He, and Jon Roozenbeek, and Jay J Van Bavel, and Sander van der Linden
August 2022, Journal of community health,
Steve Rathje, and James K He, and Jon Roozenbeek, and Jay J Van Bavel, and Sander van der Linden
April 2022, Current opinion in pediatrics,
Steve Rathje, and James K He, and Jon Roozenbeek, and Jay J Van Bavel, and Sander van der Linden
March 2022, Vaccine,
Steve Rathje, and James K He, and Jon Roozenbeek, and Jay J Van Bavel, and Sander van der Linden
April 2023, Pediatric clinics of North America,
Steve Rathje, and James K He, and Jon Roozenbeek, and Jay J Van Bavel, and Sander van der Linden
June 2022, Annals of operations research,
Copied contents to your clipboard!